Posts

Showing posts with the label docusign&#x27

Stocks making the biggest moves premarket: DocuSign, Tesla, RH and more

Image
In this article DOCU RH ZS SPCE TSLA NAVI watch now VIDEO 1:31 01:31 News Update – Pre-Markets News Briefing Check out the companies making headlines before the bell. DocuSign — Shares of the electronic signature company surged 16.4% after the DocuSign's quarterly numbers beat Wall Street expectations. DocuSign also shared revenue guidance for the third quarter above expectations and an outlook for the full year that fell in line with estimates. related investing news Barclays downgrades student loan servicer Navient on risks from Biden's debt forgiveness plan Samantha Subin 42 minutes ago Sell Virgin Galactic as space flights get delayed, Bernstein says in downgrade Samantha Subin an hour ago Zscaler — Zscaler soared 14.1% after posting strong results for the recent quarter. The cloud security company reported adjusted earnings of 25 cents a share on $318 million in revenue. Analysts surveyed by Refinitiv had anticipated earnings of 20 cents a share on revenues of $305 milli...

Stocks making the biggest moves midday: Zscaler, DocuSign, Virgin Galactic, Kroger and more

In this article REGN RH TSLA CAT The Kroger supermarket chain's headquarters is shown in Cincinnati, Ohio. Lisa Baertlein | Reuters Check out the companies making headlines in midday trading Friday. Zscaler — Zscaler surged 20% after reporting strong earnings in its most recent quarter. The company posted adjusted earnings of 25 cents per share on $318 million in revenue. Analysts surveyed by Refinitiv were expecting earnings of 20 cents per share on revenues of $305 million. DocuSign — Shares jumped 9.9% after the electronic agreement company&#x27 ;s quarterly numbers topped analyst expectations. DocuSign's revenue guidance for the third quarter was also above expectations, and its full-year outlook was in line with estimates. Regeneron Pharmaceuticals — The pharmaceutical stock gained 3.5% after Morgan Stanley upgraded shares to overweight from equal weight following the release of positive results from its eye drug trial. Regeneron soared nearly 19% the prior day on th...